Center Partnerships Diabetes Research Centers now highlights DRC Partner Institutions. Center partnerships are listed with location details and links to the partnership website. An overview of the partner institution and its research centers, institutions, and programs can also be viewed.

DIABETES RESEARCH CENTERS

Joel Habener Joel Habener MD Boston Area Boston Area
Dr. Habener is Professor of Medicine at Harvard Medical School and Associate Physician and Chief of the Laboratory of Molecular Endocrinology at Massachusetts General Hospital, Boston. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Jean E Schaffer Jean E Schaffer MD Joslin Diabetes Center Joslin Diabetes Center
The goals of our work are to characterize the fundamental cellular mechanisms of metabolic stress from substrate excess, and to understand how this process contributes to diabetes complications. Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.
Doris A Stoffers Doris A Stoffers MD PhD University of Pennsylvania University of Pennsylvania
Research in our laboratory focuses on the embryonic development and adult regeneration of the endocrine pancreas, and the relationship of defects in these pathways to the pathophysiology of diabetes mellitus, a disease caused by a deficiency in the production or action of insulin. The Penn Diabetes Research Center participates in the nationwide inter-disciplinary program established over forty years ago by the NIDDK to foster research and training in the areas of diabetes and related endocrine and metabolic disorders.
Christopher K Glass Christopher K Glass MD PhD UCSD-UCLA UCSD-UCLA
Christopher K. Glass is Professor of Cellular and Molecular Medicine and Professor of Medicine at the University of California, San Diego School of Medicine. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Michael German Michael German MD UCSF UCSF
Dr. German is the Associate Director and Clinical Director of the UCSF Diabetes Center, Director of the the Hillblom Islet Genesis Network and the UCSF NIH Diabetes Research Center (DRC). The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
Bradford Lowell MD PhD Boston Area Boston Area
The Lowell Lab utilizes genetic engineering techniques in mice, in conjunction with electrophysiology, optogenetics, pharmacogenetics and rabies mapping, to elucidate central neurocircuits controlling feeding behavior, body weight homeostasis, and fuel metabolism. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Mitchell A Lazar MD PhD University of Pennsylvania University of Pennsylvania
The Lazar laboratory is studying the transcriptional regulation of metabolism. We are particularly focused on the role played by nuclear receptors. The Penn Diabetes Research Center participates in the nationwide inter-disciplinary program established over forty years ago by the NIDDK to foster research and training in the areas of diabetes and related endocrine and metabolic disorders.
Martin G Myers Jr MD PhD University of Michigan University of Michigan
Dr. Myers’ research focuses on the processes that enable the body to respond normally to insulin, and how problems in these pathways contribute to the development of insulin resistance and diabetes. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Julian P Whitelegge Julian P Whitelegge PhD UCSD-UCLA UCSD-UCLA
Julian Whitelegge received his Ph.D. from Imperial College of Science and Technology, University of London in 1989 and became heavily involved in mass spectrometry research in the mid nineties. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Steven E Kahn MB ChB University of Washington University of Washington
Dr. Kahn received his medical degree from the University of Cape Town, South Africa. He is an endocrinologist whose research focuses on the mechanisms responsible for the critical impairments in insulin secretion that result in the development of diabetes. The University of Washington (UW) Diabetes Research Center (DRC) at the University of Washington is one of 16 Diabetes Research Centers sponsored by the National Institutes of Health to promote basic, translational, and clinical research on diabetes and related metabolic disorders.
Richard A Flavell Richard A Flavell PhD FRS Yale University Yale University
Dr. Flavell is Sterling Professor of Immunobiology at Yale University School of Medicine, and an Investigator of the Howard Hughes Medical Institute. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
William V Tamborlane William V Tamborlane MD Yale University Yale University
William V. Tamborlane, MD, is a graduate of Georgetown University School of Medicine, where he completed his residency in pediatrics before going to Yale as a postdoctoral fellow in pediatric endocrinology. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Andrea L Hevener Andrea L Hevener PhD UCSD-UCLA UCSD-UCLA
Dr. Hevener received her PhD from USC in 1998 in kinesiology and physiology and biophysics and performed a fellowship in endocrinology and metabolism at UC San Diego from 1998 to 2002. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Edward Horton Edward Horton MD Joslin Diabetes Center Joslin Diabetes Center
Dr. Horton major interests include obesity and insulin resistance as they relate to diabetes mellitus and cardiovascular disease. Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.
Gerald I Shulman Gerald I Shulman MD PhD Yale University Yale University
Dr. Shulman is the George R. Cowgill Professor of Medicine, Cellular & Molecular Physiology and Physiological Chemistry at Yale University, where he serves as Co-Director of the Yale Diabetes Research Center and Director of the Yale Mouse Metabolic Phenotyping Center. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Darleen Sandoval Darleen Sandoval PhD University of Michigan University of Michigan
Dr. Sandoval's current work utilizes basic research strategies that use a combination of molecular and physiological techniques with the goal of generating better therapeutic options for obesity and type 2 diabetes. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.

Diabetes Centers Overview

Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.

In the Spotlight

Pilot & Feasibility Study
Center Publication
UCSD-UCLA UCSD-UCLA Albert Einstein College of Medicine Einstein University of Michigan Michigan 
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis., Wheeler, Eleanor, Leong Aaron, Liu Ching-Ti, Hivert Marie-France, Strawbridge Rona J., Podmore Clara, Li Man, Yao Jie, Sim Xueling, Hong Jaeyoung, et al. , PLoS Med, 2017 Sep, Volume 14, Issue 9, p.e1002383, (2017)
NIDDK Center
The Digestive Disease Research Core Centers are part of an integrated program of support for basic and clinical research in digestive and liver diseases. Research in these Centers focuses on the etiology, treatment, and prevention of digestive and/or liver diseases.
Diabetes Resource
ImmPort is a long-term, sustainable data warehouse for the purpose of promoting re-use of immunological data generated by NIAID DAIT and DMID funded investigators. ImmPort supports analysis of flow cytometry results and HLA genetic associations.